Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) shares, rose in value, with the stock price up by 1.43% to the previous day’s close as strong demand from buyers drove the stock to $14.89.
Actively observing the price movement in the last trading, the stock closed the session at $14.68. The PE ratio was 24.44 over 12-month period. Referring to stock’s 52-week performance, its high was $17.76, and the low was $11.09. On the whole, CPRX has fluctuated by -8.48% over the past month.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CPRX’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of CPRX currently trading nearly -3.30% and -3.74% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 44.08, while the 7-day volatility ratio is showing 3.01% which for the 30-day chart, stands at 3.60%. Furthermore, Catalyst Pharmaceuticals Inc (CPRX)’s beta value is 0.90, and its average true range (ATR) is 0.58.
A comparison of Catalyst Pharmaceuticals Inc (CPRX) with its peers suggests the former has fared considerably weaker in the market. CPRX showed an intraday change of 1.43% in last session, and over the past year, it shrunk by -7.05%%.
Data on historical trading for Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) indicates that the trading volumes over the past 3 months, they’ve averaged 1.34 million. According to company’s latest data on outstanding shares, there are 107.12 million shares outstanding.
Nearly 13.93% of Catalyst Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 65.24% of the company’s shares. The stock has fallen by -11.42% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CPRX stock heading into the next quarter.
